Future studies integrating in vivo perfusion and pimonidazole assays will be valuable to validate the functional consequences of PAK1 or PAK4 modulation on vascular normalization and hypoxia in pancreatic cancer models. This evidence concerns the gene PAK4 and pancreatic neoplasm.